SCHEMBL706278

SCHEMBL706278

CCCCCCCCCCCCCCOCC(C)O

nearest known ligand 0.67

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ HSD17B10 Q99714 1/20 0.67
▸ USP2 O75604 1/20 0.64
▸ HTT P42858 2/20 0.62
▸ SPHK1 Q9NYA1 1/20 0.61
▸ LPAR5 Q9H1C0 4/20 0.53
▸ MAPT P10636 2/20 0.50
▸ MEN1 O00255 1/20 0.50
▸ THRB P10828 1/20 0.50
▸ KMT2A Q03164 1/20 0.50
▸ TDP1 Q9NUW8 1/20 0.50
▸ PRKD3 O94806 1/20 0.50
▸ PRKCG P05129 1/20 0.50
▸ PRKCB P05771 1/20 0.50
▸ PRKCA P17252 1/20 0.50
▸ PRKCH P24723 1/20 0.50
▸ PRKCI P41743 1/20 0.50
▸ PRKCE Q02156 1/20 0.50
▸ PRKCQ Q04759 1/20 0.50
▸ PRKCZ Q05513 1/20 0.50
▸ PRKCD Q05655 1/20 0.50

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4865243 1.00 HSD17B10 (0.67) HSD17B10USP2HTTSPHK1LPAR5
SCHEMBL7661581 1.00 HSD17B10 (0.67) HSD17B10USP2HTTSPHK1LPAR5
SCHEMBL9637036 1.00 HSD17B10 (0.67) HSD17B10USP2HTTSPHK1LPAR5
SCHEMBL7665310 1.00 HSD17B10 (0.67) HSD17B10USP2HTTSPHK1LPAR5
SCHEMBL7671997 1.00 HSD17B10 (0.67) HSD17B10USP2HTTSPHK1LPAR5
SCHEMBL7775489 1.00 HSD17B10 (0.67) HSD17B10USP2HTTSPHK1LPAR5
SCHEMBL15070137 1.00 HSD17B10 (0.67) HSD17B10USP2HTTSPHK1LPAR5
SCHEMBL187049 1.00 HSD17B10 (0.67) HSD17B10USP2HTTSPHK1LPAR5
SCHEMBL21046009 1.00 HSD17B10 (0.67) HSD17B10USP2HTTSPHK1LPAR5
SCHEMBL15070143 1.00 HSD17B10 (0.67) HSD17B10USP2HTTSPHK1LPAR5

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 479 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20240399294-A1 CARBON DIOXIDE ABSORBENT COMPOSITION AND METHOD FOR CAPTURING CARBON DIOXIDE USING THE SAME KOREA INSTITUTE OF ENERGY RESEARCH (KR) 2024-12-05 — — US claimed
US-20160051456-A1 MOISTURIZING LIQUID LINER FOR BARRIER LAYER DEB IP LIMITED (GB) 2016-02-25 — — US claimed
EP-2234577-A2 MOISTURIZING LIQUID LINER FOR BARRIER LAYER Evonik Goldschmidt GmbH (DE) 2010-10-06 — — EP claimed
WO-2009095351-A2 MOISTURIZING LIQUID LINER FOR BARRIER LAYER EVONIK GOLDSCHMIDT GMBH (DE) 2009-08-06 — — WO claimed
US-20090191285-A1 MOISTURIZING LIQUID LINER FOR BARRIER LAYER EVONIK DEGUSSA CORPORATION (US) 2009-07-30 — — US claimed
WO-2026102252-A1 COMPOSITION AND METHOD FOR MODULATING MICROBIOMES WITH POSTBIOTIC FERMENTS KIMBERLY-CLARK WORLDWIDE, INC. (US) 2026-05-15 — — WO disclosed
WO-2026102269-A1 HYPOGRAVITY PREPARATION OF POSTBIOTIC FERMENTS KIMBERLY-CLARK WORLDWIDE, INC. (US) 2026-05-15 — — WO disclosed
US-20260114445-A1 STABLE ANTIMICROBIAL FORMULATION CONCENTRATE KIMBERLY CLARK CO (US) 2026-04-30 — — US disclosed
US-20260021219-A1 METHODS AND ABSORBENT ARTICLES FOR INHIBITING FECAL PROTEASE ACTIVITY KIMBERLY CLARK CO (US) 2026-01-22 — — US disclosed
US-12486996-B2 Antimicrobial composition including an acyl lactylate and a glycol and methods of inhibiting microbial growth utilizing the same KIMBERLY-CLARK WORLDWIDE, INC. (US) 2025-12-02 — — US disclosed
EP-4013378-B1 WETTING COMPOSITION INCLUDING SILICONE POLYMER SOFTENING AGENT AND WET WIPES INCLUDING THE SAME KIMBERLY CLARK CO (US) 2025-06-04 — — EP disclosed
CN-120018853-A Methods and absorbent articles for inhibiting fecal protease activity 金伯利-克拉克环球有限公司 2025-05-16 — — CN disclosed
WO-2000026285-A1 GEL COMPOSITIONS PENRECO (US) 2000-05-11 — — WO disclosed
CN-1231173-A Cosmetic skin or hair care compositions containing fluorocarbons infused with carbon dioxide UNILEVER NV (NL) 1999-10-13 — — CN disclosed
US-5939083-A APPLYING TO SKIN, HAIR; DEFORMABLE, HOLLOW POLYMER PARTICLES CENTRE INTERNATIONAL DE RECHERCHES DERMATOLOGIQUES GALDERMA (FR) 1999-08-17 — — US disclosed
CN-1176783-A Borage seed oil as anti-irritant in compositions containing hydroxy acids or retinoids UNILEVER NV (NL) 1998-03-25 — — CN disclosed
EP-0342056-B1 Cosmetic composition UNILEVER PLC (GB) 1994-08-17 — — EP disclosed
EP-0342056-A2 Cosmetic composition UNILEVER PLC (GB) 1989-11-15 — — EP disclosed
US-4000315-A Cyclopropane esters for the control of mites ZOECON CORPORATION (US) 1976-12-28 — — US disclosed
US-3957849-A MITICIDES ZOECON CORPORATION (US) 1976-05-18 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20260021219-A1 METHODS AND ABSORBENT ARTICLES FOR INHIBITING FECAL PROTEASE ACTIVITY CUTA, CTRL, PEPD HSD17B10 1618/4885USP2 369/4885HTT 4053/4885
US-20260114445-A1 STABLE ANTIMICROBIAL FORMULATION CONCENTRATE CUTA, SUCLG1, SORD HSD17B10 86/4885USP2 3294/4885HTT 1627/4885
US-20090191285-A1 MOISTURIZING LIQUID LINER FOR BARRIER LAYER CUTA, LCT, AQP1 HSD17B10 120/4885USP2 2434/4885HTT 2261/4885
US-20160051456-A1 MOISTURIZING LIQUID LINER FOR BARRIER LAYER CUTA, LCT, AQP1 HSD17B10 120/4885USP2 2434/4885HTT 2261/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback